Leveraging Oncolytic Viruses to Overcome the Challenges of the Immunosuppressive Tumor Microenvironment
Time: 11:15 am
day: Conference Day 1
Details:
- Outlining the key factors that enable effective oncolytic virus entry and replication in GBM cells
- Using engineered transgenes or payloads to target and disrupt the immunosuppressive tumor microenvironment
- Overcoming immunosuppression using oncolytic viruses to counteract the challenges
- posed by GBM’s immune-resistant environment
